Collaborative R01s for Clinical and Services Studies of Mental Disorders, AIDS and Alcohol Use Disorders (R01)

The summary for the Collaborative R01s for Clinical and Services Studies of Mental Disorders, AIDS and Alcohol Use Disorders (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Collaborative R01s for Clinical and Services Studies of Mental Disorders, AIDS and Alcohol Use Disorders (R01): -Purpose. The National Institute of Mental Health (NIMH) and the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH), seek to support collaborative intervention trials in the treatment, prevention or rehabilitation of those with mental disorders and alcohol use disorders and comorbid mental disorders. Support is also sought for other collaborative clinical studies, including but not limited to mental health services research, AIDS, genetics, psychopathology, stigma, and cultural and social processes. This Funding Opportunity Announcement (FOA) should be used when two or more sites are needed to complete the study. The collaborating studies share a specific protocol across the sites and are organized as such in order to increase sample size, accelerate recruitment, or increase sample diversity and representation. In studies with a large number of sites, it is expected that one site will be submitted as a coordinating site for data management and/or other centralized administration. This FOA also supports projects involving collaboration between community-based organizations such as consumer or advocacy groups, state or local governments, and Tribal governments with universities and colleges. In the latter case especially, the combined sites would be expected to bring complementary and additive expertise to bear on a project. For a linked set of collaborative R01s, each site has its own Project Director/Principal Investigator and the program provides a mechanism for cross-site coordination, quality control, database management, statistical analysis, and reporting. -Mechanism of Support. This FOA will use the NIH Research Project Grant (R01) award mechanism. For each set of linked collaborative R01 applications, it is expected that each application will be coordinated and interlocked with the others as each application will contribute an essential component to the overall study. In the case of multi-site clinical trials, it is anticipated that the same protocol will be submitted by each site. However, there are likely to be elements unique to some sites (e.g. data coordination, fidelity assessment, statistical analyses). -Based on the particular science proposed and the determined need for substantial involvement by NIMH staff, NIMH may convert a linked set of collaborative R01s into cooperative agreement U01s or U10s, following the peer review.